140 related articles for article (PubMed ID: 18620609)
1. Early distant relapse after optimal local control in locally advanced rectal cancer.
Gallego-Plazas J; Menarguez-Pina F; Martinez-Banaclocha N; Pons-Sanz V; Mingol-Navarro F; Ruiz-Macia JA; Macia-Escalante S
Int Semin Surg Oncol; 2008 Jul; 5():18. PubMed ID: 18620609
[TBL] [Abstract][Full Text] [Related]
2. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
[No Abstract] [Full Text] [Related]
3. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
4. Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer.
Rödel C; Grabenbauer GG; Matzel KE; Schick C; Fietkau R; Papadopoulos T; Martus P; Hohenberger W; Sauer R
Dis Colon Rectum; 2000 Mar; 43(3):312-9. PubMed ID: 10733111
[TBL] [Abstract][Full Text] [Related]
5. New Scale Predicting Distant Recurrence in Locally Advanced Lower Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy.
Nakagawa R; Kumamoto T; Maeda F; Tani K; Kondo H; Koshino K; Kaneko Y; Bamba Y; Ogawa S; Inoue Y; Itabashi M; Yamaguchi S
Anticancer Res; 2023 May; 43(5):2179-2184. PubMed ID: 37097680
[TBL] [Abstract][Full Text] [Related]
6. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
7. Oncologic and survival outcomes in elderly patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy and total mesorectal excision.
He F; Chen M; Xiao WW; Zhang Q; Liu Y; Zheng J; Wan XB; Gao YH
Jpn J Clin Oncol; 2021 Aug; 51(9):1391-1399. PubMed ID: 34155513
[TBL] [Abstract][Full Text] [Related]
8. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
9. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
[TBL] [Abstract][Full Text] [Related]
10. Predicting prognosis according to preoperative chemotherapy response in patients with locally advanced lower rectal cancer.
Shiraishi T; Sasaki T; Ikeda K; Tsukada Y; Nishizawa Y; Ito M
BMC Cancer; 2019 Dec; 19(1):1222. PubMed ID: 31842797
[TBL] [Abstract][Full Text] [Related]
11. What is the significance of the circumferential margin in locally advanced rectal cancer after neoadjuvant chemoradiotherapy?
Trakarnsanga A; Gonen M; Shia J; Goodman KA; Nash GM; Temple LK; Guillem JG; Paty PB; Garcia-Aguilar J; Weiser MR
Ann Surg Oncol; 2013 Apr; 20(4):1179-84. PubMed ID: 23328971
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
13. Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study.
Yu X; Wang QX; Xiao WW; Chang H; Zeng ZF; Lu ZH; Wu XJ; Chen G; Pan ZZ; Wan DS; Ding PR; Gao YH
Cancer Commun (Lond); 2018 May; 38(1):24. PubMed ID: 29784042
[TBL] [Abstract][Full Text] [Related]
14. Postoperative recurrence in locally advanced rectal cancer: how does neoadjuvant treatment affect recurrence pattern?
Okamura R; Itatani Y; Fujita Y; Hoshino N; Okumura S; Nishiyama K; Hida K; Obama K
World J Surg Oncol; 2023 Aug; 21(1):247. PubMed ID: 37587422
[TBL] [Abstract][Full Text] [Related]
15. Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy.
Sclafani F; Brown G; Cunningham D; Rao S; Tekkis P; Tait D; Morano F; Baratelli C; Kalaitzaki E; Rasheed S; Watkins D; Starling N; Wotherspoon A; Chau I
Oncologist; 2017 Jun; 22(6):728-736. PubMed ID: 28476941
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of progression-free survival for locally advanced rectal cancer by MRI after neoadjuvant chemoradiotherapy and total mesorectal excision].
Zhang JX; Yang Z; Fan P; Zhang JJ; Xin L; Hou LN; Du XS; Yang XT
Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):121-126. PubMed ID: 29502372
[No Abstract] [Full Text] [Related]
17. Timing to achieve the best recurrence-free survival after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: experience in a large-volume center in China.
Wang X; Zheng Z; Zhu H; Yu Q; Huang S; Lu X; Huang Y; Chi P
Int J Colorectal Dis; 2021 May; 36(5):1007-1016. PubMed ID: 33398511
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of different radiotherapy doses in neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Zhang Y; Jiang P; Zhu H; Dong B; Zhai H; Chen Z
J Gastrointest Oncol; 2021 Aug; 12(4):1531-1542. PubMed ID: 34532108
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant concurrent chemoradiotherapy using infusional gemcitabine in locally advanced rectal cancer: A phase II trial.
Bazarbashi S; Elshenawy MA; Badran A; Aljubran A; Alzahrani A; Almanea H; Alsuhaibani A; Alashwah A; Neimatallah M; Abduljabbar A; Ashari L; Alhomoud S; Ghebeh H; Elhassan T; Alsanea N; Mohiuddin M
Cancer Med; 2022 May; 11(10):2056-2066. PubMed ID: 35146939
[TBL] [Abstract][Full Text] [Related]
20. Optimal waiting period to surgical treatment after neoadjuvant chemoradiotherapy for locally advanced rectum cancer: a retrospective observational study.
Aslanov K; Atici AE; Karaman D; Bozkurtlar E; Yegen ŞC
Langenbecks Arch Surg; 2023 May; 408(1):210. PubMed ID: 37227524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]